I. Alhamadani, M. Alzyadi, and M. Majeed, “Prognostic Significance of the CXCL11/CXCL9/CD163 Immune Signature in Triple-Negative Breast Cancer: A Bioinformatics and Survival Analysis: CXCL11/CXCL9 prognostic value”, Arch Breast Cancer, vol. 13, no. 2, pp. 154–165, Apr. 2026.